Ro 205-2349
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ro 205-2349, covering 2016-08-24 to 2023-04-28. Get the full timeline:
Most recent: Clinical Trial Update: Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus [Phase 2]